Results 241 to 250 of about 2,236,849 (269)
Some of the next articles are maybe not open access.
[Carbapenem resistance in enterobacteria].
Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne, 2009Carbapenems are the drugs of choice in the treatment of serious infections caused by multiresistant Gram-negative bacteria. Clinically and epidemiologically, resistance to these beta-lactams poses the highest risk. In enterobacteria, two common mechanisms can cause the resistance to carbapenems: (1) hydrolysis of carbapenems by beta-lactamases and (2 ...
J, Hrabák, E, Chudácková
openaire +1 more source
Carbapenem-resistance mechanisms of multidrug-resistant Pseudomonas aeruginosa
Journal of Medical Microbiology, 2013Clonal dissemination of multidrug-resistant Pseudomonas aeruginosa (MDRPA) is a major concern worldwide. The aim of this study was to explore the mechanisms leading to the carbapenem resistance of an MDRPA clone. Isolates were obtained from a surgical wound, sputum, urine and a blood culture.
Ester, Fusté +5 more
openaire +2 more sources
Mechanisms of fosfomycin resistance in carbapenem-resistant Enterobacter sp .
International Journal of Antimicrobial Agents, 2017We report on fosfomycin susceptibility and mechanisms of resistance in clinical strains of blaKPC-positive Enterobacter sp. (n = 19). A total of 14 strains (74%) were susceptible to fosfomycin; 8 strains (42%) were positive for fosA and no strains were positive for FosA3 or FosC2. FosA presence does not appear to correlate with susceptibility.
Bryan P, White +5 more
openaire +2 more sources
Role of glycosylation in bacterial resistance to carbapenems
World Journal of Microbiology and BiotechnologyCarbapenems are a class of β-lactam antibacterial drugs with a broad antibacterial spectrum and strong activity, commonly used to treat serious bacterial infections. However, improper or excessive use of carbapenems can lead to increased bacterial resistance, which is a significant concern as they are often used as last resort for treating multidrug ...
Jing, Dang +5 more
openaire +2 more sources
Carbapenem-resistant Enterobacterales in the USA
The Lancet Infectious Diseases, 2020Sumanth, Gandra, Carey-Ann D, Burnham
openaire +2 more sources
Screening for carbapenem-resistant bacteria
The Lancet Infectious Diseases, 2005James S, Soothill, Paul E, Lock
openaire +2 more sources
A Review of Carbapenem Resistance in Enterobacterales and Its Detection Techniques
Microorganisms, 2023Evangelyn Alocilja +1 more
exaly